Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy.

Kim SH, Park WS, Kim SH, Park B, Joo J, Lee GK, Joung JY, Seo HK, Chung J, Lee KH.

PLoS One. 2016 Mar 16;11(3):e0151646. doi: 10.1371/journal.pone.0151646. eCollection 2016.

2.

Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial.

Steigler A, Denham JW, Lamb DS, Spry NA, Joseph D, Matthews J, Atkinson C, Turner S, North J, Christie D, Tai KH, Wynne C.

Prostate Cancer. 2012;2012:814724. doi: 10.1155/2012/814724. Epub 2012 Dec 24.

3.

Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group.

Teeter AE, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ.

Urology. 2011 Jan;77(1):149-53. doi: 10.1016/j.urology.2010.04.071. Epub 2010 Dec 8.

4.

External validation of the SEARCH model for predicting aggressive recurrence after radical prostatectomy: results from the Duke Prostate Center Database.

Teeter AE, Sun L, Moul JW, Freedland SJ.

BJU Int. 2010 Sep;106(6):796-800. doi: 10.1111/j.1464-410X.2010.09214.x. Epub 2010 Feb 11.

5.

Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.

Ray ME, Bae K, Hussain MH, Hanks GE, Shipley WU, Sandler HM.

J Natl Cancer Inst. 2009 Feb 18;101(4):228-36. doi: 10.1093/jnci/djn489. Epub 2009 Feb 10.

6.

Comparison of models to predict clinical failure after radical prostatectomy.

Eggener SE, Vickers AJ, Serio AM, Donovan MJ, Khan FM, Bayer-Zubek V, Verbel D, Cordon-Cardo C, Reuter VE, Bianco FJ Jr, Scardino PT.

Cancer. 2009 Jan 15;115(2):303-10. doi: 10.1002/cncr.24016.

7.
8.

Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost.

Singh AK, Guion P, Susil RC, Citrin DE, Ning H, Miller RW, Ullman K, Smith S, Crouse NS, Godette DJ, Stall BR, Coleman CN, Camphausen K, Ménard C.

Radiat Oncol. 2006 Aug 16;1:28.

Supplemental Content

Support Center